Clinical Trial Update: Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing romosozumab versus denosumab to improve bone mineral density and bone architecture in subacute spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Spinal Cord Injury

Drugs mentioned

• Denosumab (denosumab)
• Romosozumab (romosozumab)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Osteoporosis, Spinal Cord Injuries | Phase 4 | Status: ACTIVE_NOT_RECRUITING